MX2022004713A - Derivados de tiofeno como inhibidores de xantina oxidasa y aplicacion de los mismos. - Google Patents
Derivados de tiofeno como inhibidores de xantina oxidasa y aplicacion de los mismos.Info
- Publication number
- MX2022004713A MX2022004713A MX2022004713A MX2022004713A MX2022004713A MX 2022004713 A MX2022004713 A MX 2022004713A MX 2022004713 A MX2022004713 A MX 2022004713A MX 2022004713 A MX2022004713 A MX 2022004713A MX 2022004713 A MX2022004713 A MX 2022004713A
- Authority
- MX
- Mexico
- Prior art keywords
- application
- xanthine oxidase
- oxidase inhibitors
- thiophene derivatives
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Una clase de inhibidores de xantina oxidasa (XO), y aplicación de los mismos en la preparación de fármacos para tratar enfermedades relacionadas con XO. Se describe específicamente un compuesto representado por la fórmula (I) y una sal farmacéuticamente aceptable del mismo. (ver Fórmula).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911049951 | 2019-10-30 | ||
CN202010110482 | 2020-02-21 | ||
PCT/CN2020/125191 WO2021083319A1 (zh) | 2019-10-30 | 2020-10-30 | 作为黄嘌呤氧化酶抑制剂的噻吩衍生物及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022004713A true MX2022004713A (es) | 2022-05-11 |
Family
ID=75714861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022004713A MX2022004713A (es) | 2019-10-30 | 2020-10-30 | Derivados de tiofeno como inhibidores de xantina oxidasa y aplicacion de los mismos. |
Country Status (8)
Country | Link |
---|---|
US (1) | US20230322703A1 (es) |
EP (1) | EP4053114A4 (es) |
JP (1) | JP7362916B2 (es) |
CN (1) | CN114555578B (es) |
AU (1) | AU2020374919B9 (es) |
BR (1) | BR112022007543A2 (es) |
MX (1) | MX2022004713A (es) |
WO (1) | WO2021083319A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20240004711A (ko) * | 2021-04-29 | 2024-01-11 | 둥바오 퍼플 스타 (항저우) 바이오파마슈티컬 컴퍼니 리미티드 | 티오펜 유도체의 결정형 및 이의 제조 방법 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2623327A1 (en) * | 2005-10-07 | 2007-04-19 | Kissei Pharmaceutical Co., Ltd. | Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
JP4930008B2 (ja) | 2006-11-22 | 2012-05-09 | いすゞ自動車株式会社 | 車両用動力伝達装置の制御装置 |
PL2133332T3 (pl) * | 2007-04-11 | 2014-02-28 | Kissei Pharmaceutical | Pochodna aza(indolu) i jej zastosowanie do celów medycznych |
RU2515968C2 (ru) * | 2007-04-11 | 2014-05-20 | Киссеи Фармасьютикал Ко., Лтд. | 5-членное гетероциклическое соединение и его применение для лекарственных целей |
JPWO2010044403A1 (ja) * | 2008-10-15 | 2012-03-15 | キッセイ薬品工業株式会社 | 5員環ヘテロアリール誘導体及びその医薬用途 |
KR20140060535A (ko) * | 2011-08-24 | 2014-05-20 | 깃세이 야쿠힌 고교 가부시키가이샤 | 축합 헤테로환 유도체 및 그 의약용도 |
EP3344604B1 (en) * | 2015-09-02 | 2020-11-04 | Sunshine Lake Pharma Co., Ltd. | Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof |
WO2017202291A1 (zh) * | 2016-05-23 | 2017-11-30 | 南京明德新药研发股份有限公司 | 噻吩化合物及其合成方法和其在医药上的应用 |
-
2020
- 2020-10-30 BR BR112022007543A patent/BR112022007543A2/pt unknown
- 2020-10-30 EP EP20883025.7A patent/EP4053114A4/en active Pending
- 2020-10-30 WO PCT/CN2020/125191 patent/WO2021083319A1/zh unknown
- 2020-10-30 AU AU2020374919A patent/AU2020374919B9/en active Active
- 2020-10-30 CN CN202080072431.2A patent/CN114555578B/zh active Active
- 2020-10-30 MX MX2022004713A patent/MX2022004713A/es unknown
- 2020-10-30 JP JP2022523155A patent/JP7362916B2/ja active Active
- 2020-10-30 US US17/766,435 patent/US20230322703A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2022553682A (ja) | 2022-12-26 |
AU2020374919B9 (en) | 2024-02-29 |
US20230322703A1 (en) | 2023-10-12 |
CN114555578B (zh) | 2024-03-26 |
BR112022007543A2 (pt) | 2022-07-12 |
JP7362916B2 (ja) | 2023-10-17 |
AU2020374919B2 (en) | 2024-02-22 |
EP4053114A4 (en) | 2023-10-25 |
AU2020374919A1 (en) | 2022-04-21 |
EP4053114A1 (en) | 2022-09-07 |
WO2021083319A1 (zh) | 2021-05-06 |
CN114555578A (zh) | 2022-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019003143A (es) | Compuesto heterociclico sustituido con alquinilo, su metodo de preparacion y su uso medico. | |
NZ796075A (en) | Five-membered heteroaromatic imidazole compound and use thereof | |
MX2022001908A (es) | Inhibidores de shp2 fosfatasa de tipo pirazolo[3,4-b]pirazina. | |
AU2009258496A8 (en) | Sulfur-containing heterocyclic derivative having beta-secretase-inhibiting activity | |
PH12021550825A1 (en) | Quinoline derivatives as alpha4beta7 integrin inhibitors | |
PH12020552017A1 (en) | 2,3-dihydro-1h-pyrrolizine-7-formamide derivative and application thereof | |
MX348860B (es) | Derivados de pirazoloespirocetona para usarse como inhibidores de acetil-coa carboxilasa. | |
SA519402103B1 (ar) | 1,6-naphthyridine مشتقات 1، 6 نفثيرايدين CDK4/6 على شكل مثبط | |
MX2012003007A (es) | Sulfonamidas como inhibidores de las proteinas de la familia bcl-2 para el tratamiento de cancer. | |
MX2024000299A (es) | Compuestos antivirales. | |
AU2020288567A8 (en) | Pyrrolopyrimidine compound and use thereof | |
PH12021550713A1 (en) | Medicament for the treatment of chronic cough | |
SA519410865B1 (ar) | مركب حلقي شبيه بكُومارين بوصفه مثبط mek واستخدامه | |
MX2021012105A (es) | Compuestos de pirrol. | |
MX2021007247A (es) | Derivados de rapamicina. | |
MX2019006612A (es) | Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta (pi3kdelta). | |
MX2021005877A (es) | Compuesto heterociclico. | |
MX2018009458A (es) | Derivado de sulfonamida heterociclico y medicina que contiene el mismo. | |
SA521431279B1 (ar) | D1 مشتق تتراهيدرو إيزوكينولين بديل كمعدِّل تفارغي إيجابي | |
MX2020002630A (es) | Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta. | |
MX2023003576A (es) | Compuesto como inhibidor de la akt cinasa. | |
MX2022003270A (es) | Compuesto de amida heterocíclica, sal farmacéuticamente aceptable delmismo y método de preparación y uso del mismo. | |
MX2024001352A (es) | Inhibidor novedoso de la poli(adp-ribosa) polimerasa y uso del mismo. | |
MX2021015827A (es) | Antagonista de neurokinin -1. | |
MX2021009971A (es) | Compuesto heterociclico, composicion farmaceutica que lo comprende, metodo para su preparacion, y uso de estos. |